Evidence map›Paper›PMID 28277349›Full record

Trial reportObstetrics and gynecology2017

Missed Opportunities for Prevention of Mother-to-Child Transmission of Human Immunodeficiency Virus.

Gwendolyn B Scott, Susan B Brogly, Daniel Muenz, Alice M Stek, Jennifer S Read, International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) P1025 Study Team

Registry-linked trialAbstract readClinical Trial
In one paragraph

Trial report in Obstetrics and gynecology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00028145 (Perinatal Core Protocol), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00028145 completednot on this map

Perinatal Core Protocol

TypeobservationalSponsorInternational Maternal Pediatric Adolescent AIDS Clinical Trials GroupRan2002 to 2013Enrolled3,090ConditionsHIV Infections, Pregnancy Complications, InfectiousArmsAdherence assessment
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Observational
  6. HIV Screening During Pregnancy in a U.S. HIV Epicenter.Infectious diseases in obstetrics and gynecology · 2020
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Gwendolyn B ScottDivision of Pediatric Infectious Disease and Immunology University of Miami Miller School of Medicine, Miami, Florida; the Department of Surgery, Queen's University, Kingston, Ontario, Canada; the Department of Biostatistics, University of Michigan, Ann Arbor, Michigan; the Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles, California; and the Pediatric, Adolescent and Maternal AIDS Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.
Susan B Brogly
Daniel Muenz
Alice M Stek
Jennifer S Read
International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) P1025 Study Team
Eunice Kennedy Shriver National Institute of Child Health and Human Development · US

Funding

LOC-IMPAACT Leadership GroupPharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant Women in the USUM1AI068632 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI Jennifer Jao, Sharon A Nachman · 2011 to 2026
$278.1M
Statistical and Data Management Center-Pediatric,Adolescent, and Maternal CTGUM1AI068616 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Sean Scott Brummel, Marlene Ann Cooper · 2011 to 2026
$155.6M
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) GroupU01AI068632 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI JACKSON, J BROOKS · 2006 to 2010
$109.7M
Statistical and Data Management Center-Pediatric,Adolescent, and Maternal CTGU01AI068616 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI SHAPIRO, DAVID ERIC · 2006 to 2010
$38.6M
Miami Treatment and Prevention Clinical Trials Unit (CTU)UM1AI069477 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI JAYAWEERA, DUSHYANTHA, SCOTT, GWENDOLYN BARBARA · 2012 to 2020
$9.2M
University of Miami Pediatric Perinatal HIV/AIDS Clinical Trails UnitU01AI069451 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SCOTT, GWENDOLYN BARBARA · 2007 to 2011
$5.5M
NIAID NIH HHS U01 AI068616NIAID NIH HHS U01 AI068632NIAID NIH HHS U01 AI069451NIAID NIH HHS UM1 AI068616NIAID NIH HHS UM1 AI069477
6 · The paper itself

Abstract

objectiveTo identify missed opportunities for prevention of mother-to-child transmission of human immunodeficiency virus (HIV).

methodsData regarding HIV-infected children born between 2002 and 2009 to HIV-infected women enrolled in the U.S. International Maternal Pediatric Adolescent AIDS Clinical Trials prospective cohort study (protocol P1025) were reviewed. The characteristics of the HIV-infected infants and their mothers and the mothers' clinical management are described.

resultsTwelve cases of mother-to-child transmission of HIV occurred among 1,857 liveborn neonates, for a prevalence of 0.65 per 100 live births to HIV-infected women (95% confidence interval 0.33-1.13). Four transmissions occurred in utero, three were peripartum transmissions, and the timing of transmission for five neonates was unable to be determined. None were breastfed. Seven women had plasma viral loads greater than 400 copies/mL near delivery. Six women had less than 11 weeks of antiretroviral therapy during pregnancy; three of these women had premature deliveries. One woman received no antiretroviral therapy during pregnancy because she was diagnosed with HIV postpartum. Six had poor to moderate adherence to antiretroviral therapy. Four of the five mothers with viral loads greater than 1,000 copies/mL delivered preterm neonates. There were five women who delivered by cesarean; four were nonelective cesarean deliveries and only one was an elective cesarean delivery for HIV prevention.

conclusionDespite access to high-level care and follow-up, a small proportion of HIV-infected women transmitted the virus to their neonates. This case series provides insight into factors contributing to HIV perinatal transmission and can inform the development of new strategies for prevention of mother-to-child transmission of HIV. CLINICAL

trial registrationClinicalTrials.gov, https://clinicaltrials.gov, NCT00028145.

Indexed as

Health Services MisuseHIV InfectionsInfectious Disease Transmission, VerticalPerinatal CarePregnancy Complications, InfectiousAdultAnti-Retroviral AgentsDelivery, ObstetricFemaleHealth Services AccessibilityHumansInfant, NewbornNeeds AssessmentPregnancyQuality ImprovementUnited StatesAnti-Retroviral Agents

Identifiers

PMID28277349
PMCPMC6122962
OpenAlexW2593373383

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.